Review of National Spontaneous Reporting Schemes: Strengths and Weaknesses

Author： Hughes M.L. Whittlesea C.M.C. Luscombe D.K.

ISSN： 1176-2551

Source： Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol.21, Iss.4, 2002-01, pp. : 231-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study

By Mas Sergi LLerena Adrián Saíz Jerónimo Bernardo Miquel Lafuente Amalia

Pharmacogenomics, Vol. 13, Iss. 15, 2012-11 ,pp. : 1773-1782

Future Medicine

Access to resources Recommend Favorite

Patient versus Healthcare Professional Spontaneous Adverse Drug Reaction Reporting: A Systematic Review

By Inch Jackie

Drug Safety, Vol. 35, Iss. 10, 2012-10 ,pp. : 807-818

Adis International

Access to resources Recommend Favorite

Improving Pharmacovigilance Beyond Spontaneous Reporting

By de Abajo Francisco J.

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 4, 2005-01 ,pp. : 209-218

Adis International

Access to resources Recommend Favorite

Flupirtine-induced liver injury—Seven cases from the Berlin Case–control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database

By Douros Antonios Bronder Elisabeth Andersohn Frank Klimpel Andreas Thomae Michael Orzechowski Hans-Dieter Kreutz Reinhold Garbe Edeltraut

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 453-459

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Reporting Bias in Postmarketing Risk Assessment Based on Spontaneous Reporting Systems

By Alemayehu Demissie

Pharmaceutical Medicine, Vol. 23, Iss. 4, 2009-08 ,pp. : 195-200

Adis International

Access to resources Recommend Favorite